登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 6413 条符合本次的查询结果， 用时 9.2465649 秒

6321. Hierarchical Payment Models-A Path for Coordinating Population- and Episode-Based Payment Models.

作者: William H Shrank.;Michael E Chernew.;Amol S Navathe.
来源: JAMA. 2022年327卷5期423-424页

6322. Realizing the Potential of Anti-SARS-CoV-2 Monoclonal Antibodies for COVID-19 Management.

作者: Jonathan Z Li.;Rajesh T Gandhi.
来源: JAMA. 2022年327卷5期427-429页

6323. Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.

作者: Meagan P O'Brien.;Eduardo Forleo-Neto.;Neena Sarkar.;Flonza Isa.;Peijie Hou.;Kuo-Chen Chan.;Bret J Musser.;Katharine J Bar.;Ruanne V Barnabas.;Dan H Barouch.;Myron S Cohen.;Christopher B Hurt.;Dale R Burwen.;Mary A Marovich.;Elizabeth R Brown.;Ingeborg Heirman.;John D Davis.;Kenneth C Turner.;Divya Ramesh.;Adnan Mahmood.;Andrea T Hooper.;Jennifer D Hamilton.;Yunji Kim.;Lisa A Purcell.;Alina Baum.;Christos A Kyratsous.;James Krainson.;Richard Perez-Perez.;Rizwana Mohseni.;Bari Kowal.;A Thomas DiCioccio.;Gregory P Geba.;Neil Stahl.;Leah Lipsich.;Ned Braunstein.;Gary Herman.;George D Yancopoulos.;David M Weinreich.; .
来源: JAMA. 2022年327卷5期432-441页
Easy-to-administer anti-SARS-CoV-2 treatments may be used to prevent progression from asymptomatic infection to symptomatic disease and to reduce viral carriage.

6324. Mitigating the Long-term Health Risks of Adverse Pregnancy Outcomes.

作者: Lynn M Yee.;Eliza C Miller.;Philip Greenland.
来源: JAMA. 2022年327卷5期421-422页

6325. US Insurer Spending on Ivermectin Prescriptions for COVID-19.

作者: Kao-Ping Chua.;Rena M Conti.;Nora V Becker.
来源: JAMA. 2022年327卷6期584-587页
This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.

6326. Preparing Hospitals' Medical Oxygen Delivery Systems for a Respiratory "Twindemic".

作者: Melissa Suran.
来源: JAMA. 2022年327卷5期411-413页

6327. Study: Business Booms for Unlicensed and Unproven Stem Cell Treatments.

作者: Rita Rubin.
来源: JAMA. 2022年327卷5期414-415页

6328. COVID-19 Vaccines Have Been Available in the US for More Than a Year-What's Been Learned and What's Next?

作者: Rita Rubin.
来源: JAMA. 2022年327卷6期513-516页

6329. Studies Suggest COVID-19 Vaccine Boosters Save Lives.

作者: Jennifer Abbasi.
来源: JAMA. 2022年327卷2期115页

6330. Homing In On a SARS-CoV-2 Correlate of Protection.

作者: Jennifer Abbasi.
来源: JAMA. 2022年327卷2期115页

6331. COVID-19 Vaccine Focused on T-Cell Response Promising in Early Trial.

作者: Jennifer Abbasi.
来源: JAMA. 2022年327卷2期115页

6332. Duration of Anticoagulant Treatment for Acute Provoked Venous Thromboembolism in Pediatric Patients.

作者: Benoît Mâsse.;Nancy Robitaille.;Jacques Lacroix.
来源: JAMA. 2022年327卷2期124-125页

6333. Screening for Chronic Obstructive Pulmonary Disease: Unmet Needs and Future Considerations.

作者: Barbara P Yawn.;Nancy K Leidy.;Fernando Martinez.
来源: JAMA. 2022年327卷2期126-128页

6334. Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies.

作者: Bijan A Niknam.;Jose R Zubizarreta.
来源: JAMA. 2022年327卷2期173-174页

6335. A Plea for Accuracy.

来源: JAMA. 2022年327卷2期187页

6336. Important Contribution to Egyptian Medicine.

来源: JAMA. 2022年327卷2期187页

6337. Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients.

作者: Cheng-Yi Wang.;Chao-Hsien Chen.;Chih-Cheng Lai.
来源: JAMA. 2022年327卷2期181-182页

6338. Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.

作者: Anne L Wyllie.;Prem K Premsrirut.
来源: JAMA. 2022年327卷2期182-183页

6339. A Pulmonary Embolism Diagnostic Strategy in Patients Hospitalized for COPD Exacerbation.

作者: Wei Xiong.;Xuejun Guo.
来源: JAMA. 2022年327卷2期184页

6340. Effect of Lactobacillus rhamnosus GG on Incident Pneumonia in Critically Ill Patients-Reply.

作者: Jennie Johnstone.;Diane Heels-Ansdell.;Deborah Cook.
来源: JAMA. 2022年327卷2期182页
共有 6413 条符合本次的查询结果， 用时 9.2465649 秒